Stephen Ryder
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Liver physiology and pathology
- Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 140
- Hepatitis C virus research 65
- Liver Disease and Transplantation 32
- Liver Diseases and Immunity 25
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Epidemiology 64
- Liver Disease Diagnosis and Treatment 37
- Hepatitis B Virus Studies 15
- Substance Abuse Treatment and Outcomes 11
- Co-authors
- Guruprasad Padur Aithal (23 shared papers)William Rosenberg (17 shared papers)William Lucien Irving (19 shared papers)Indra Neil Guha (12 shared papers)Julie Parkes (7 shared papers)Paul J. Roderick (5 shared papers)Jonathan Michael Rhodes (9 shared papers)Mark R. Thursz (10 shared papers)
- Journals
- Journal of Hepatology (30 papers)Journal of Viral Hepatitis (13 papers)Gastroenterology (11 papers)Alimentary Pharmacology & Therapeutics (11 papers)Gut (8 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stephen Ryder
229 papers receiving 15.2k citations
Stephen Ryder's Hit Papers
Peers
Comparison fields: 5 of 146
- Hepatology 7.8k
- Epidemiology 5.2k
- Pathology and Forensic Medicine 1.1k
- Immunology 390
- Infectious Diseases 247
Countries citing papers authored by Stephen Ryder
This map shows the geographic impact of Stephen Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Ryder more than expected).
Fields of papers citing papers by Stephen Ryder
This network shows the impact of papers produced by Stephen Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Ryder. The network helps show where Stephen Ryder may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Ryder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Hit paper breakdown → | 2016 | 1661 |
| 2 | Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study Hit paper breakdown → | 2018 | 1361 |
| 3 | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers Hit paper breakdown → | 2007 | 637 |
| 4 | Prednisolone or Pentoxifylline for Alcoholic Hepatitis Hit paper breakdown → | 2015 | 616 |
| 5 | Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis Hit paper breakdown → | 2008 | 605 |
| 6 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Hit paper breakdown → | 2022 | 489 |
| 7 | Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis Hit paper breakdown → | 2014 | 484 |
| 8 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Hit paper breakdown → | 2014 | 416 |
| 9 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Hit paper breakdown → | 2020 | 414 |
| 10 | The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology Hit paper breakdown → | 2020 | 369 |
| 11 | 2003 | 341 | |
| 12 | 1995 | 304 | |
| 13 | Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study Hit paper breakdown → | 2023 | 275 |
| 14 | A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis Hit paper breakdown → | 2021 | 246 |
| 15 | 2004 | 234 | |
| 16 | 2020 | 233 | |
| 17 | 2001 | 228 | |
| 18 | 2015 | 227 | |
| 19 | 2014 | 219 | |
| 20 | 2017 | 204 |
About Stephen Ryder
Stephen Ryder is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Oncology and Surgery, having authored 237 papers that have together received 15.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (65 papers), Liver Disease Diagnosis and Treatment (37 papers), Liver Disease and Transplantation (32 papers), Liver Diseases and Immunity (25 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Alcohol Consumption and Health Effects (18 papers), Hepatitis B Virus Studies (15 papers) and Substance Abuse Treatment and Outcomes (11 papers). The work is most often cited by research in Hepatology (7.8k citations), Epidemiology (5.2k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (390 citations) and Infectious Diseases (247 citations). Stephen Ryder has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Guruprasad Padur Aithal, William Rosenberg, William Lucien Irving, Indra Neil Guha, Julie Parkes, Paul J. Roderick, Jonathan Michael Rhodes, Mark R. Thursz, Philip Kaye and Adam Lawson. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Gastroenterology, Alimentary Pharmacology & Therapeutics and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.